RCMI Coordinating Center (RCMI CC)
Home
About
RCMI Coordinating Center
Overview
Sharing Data
Network Graph
Help
History (0)
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Bargonetti, Jill
One or more keywords matched the following items that are connected to
Bargonetti, Jill
Item Type
Name
Academic Article
p53 binds to a constitutively nucleosome free region of the mdm2 gene.
Academic Article
DNA adducts of decarbamoyl mitomycin C efficiently kill cells without wild-type p53 resulting from proteasome-mediated degradation of checkpoint protein 1.
Academic Article
A p53-independent role of Mdm2 in estrogen-mediated activation of breast cancer cell proliferation.
Academic Article
A DNA damage signal is required for p53 to activate gadd45.
Academic Article
8-Amino-adenosine activates p53-independent cell death of metastatic breast cancers.
Academic Article
Dietary downregulation of mutant p53 levels via glucose restriction: mechanisms and implications for tumor therapy.
Academic Article
Mutant p53 disrupts mammary tissue architecture via the mevalonate pathway.
Academic Article
Site-specific binding of wild-type p53 to cellular DNA is inhibited by SV40 T antigen and mutant p53.
Academic Article
C. elegans CEP-1/p53 and BEC-1 are involved in DNA repair.
Academic Article
Decarbamoyl mitomycin C (DMC) activates p53-independent ataxia telangiectasia and rad3 related protein (ATR) chromatin eviction.
Academic Article
Mutant p53 cooperates with the SWI/SNF chromatin remodeling complex to regulate VEGFR2 in breast cancer cells.
Academic Article
Endogenous human MDM2-C is highly expressed in human cancers and functions as a p53-independent growth activator.
Academic Article
Impedimetric detection of mutant p53 biomarker-driven metastatic breast cancers under hyposmotic pressure.
Academic Article
Proteome-wide analysis of mutant p53 targets in breast cancer identifies new levels of gain-of-function that influence PARP, PCNA, and MCM4.
Academic Article
Homozygous mdm2 SNP309 cancer cells with compromised transcriptional elongation at p53 target genes are sensitive to induction of p53-independent cell death.
Academic Article
Hot Spot Mutation in TP53 (R248Q) Causes Oncogenic Gain-of-Function Phenotypes in a Breast Cancer Cell Line Derived from an African American patient.
Academic Article
Estrogen-activated MDM2 disrupts mammary tissue architecture through a p53-independent pathway.
Academic Article
DNA-binding properties of the p53 tumor suppressor protein.
Academic Article
p53, through p21 (WAF1/CIP1), induces cyclin D1 synthesis.
Academic Article
MDM2, MDM2-C, and mutant p53 expression influence breast cancer survival in a multiethnic population.
Academic Article
A proteolytic fragment from the central region of p53 has marked sequence-specific DNA-binding activity when generated from wild-type but not from oncogenic mutant p53 protein.
Academic Article
Context-dependent roles of MDMX (MDM4) and MDM2 in breast cancer proliferation and circulating tumor cells.
Academic Article
The p53 protein is an unusually shaped tetramer that binds directly to DNA.
Academic Article
Gain-of-Function Mutant p53 R273H Interacts with Replicating DNA and PARP1 in Breast Cancer.
Academic Article
A Protein in the Yeast Saccharomyces cerevisiae Presents DNA Binding Homology to the p53 Checkpoint Protein and Tumor Suppressor.
Academic Article
Gain-of-function mutant p53: history and speculation.
Academic Article
In vivo footprinting and DNA affinity chromatography for analysis of p53 DNA binding ability.
Academic Article
Wild-type p53 activates transcription in vitro.
Academic Article
Wild-type p53 mediates positive regulation of gene expression through a specific DNA sequence element.
Academic Article
Mutant p53 forms a complex with Sp1 on HIV-LTR DNA.
Academic Article
Camptothecin and Zeocin can increase p53 levels during all cell cycle stages.
Academic Article
Differential activation of p53 by the various adducts of mitomycin C.
Academic Article
Inhibition of human p53 basal transcription by down-regulation of protein kinase Cdelta.
Academic Article
Wild-type but not mutant p53 immunopurified proteins bind to sequences adjacent to the SV40 origin of replication.
Academic Article
Phospholipase D elevates the level of MDM2 and suppresses DNA damage-induced increases in p53.
Academic Article
A chromatin-associated and transcriptionally inactive p53-Mdm2 complex occurs in mdm2 SNP309 homozygous cells.
Academic Article
Functional consequences of the interactions of the p53 tumor suppressor protein and SV40 large tumor antigen.
Academic Article
A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans.
Academic Article
Mouse double minute 2 associates with chromatin in the presence of p53 and is released to facilitate activation of transcription.
Academic Article
Mutant p53 in MDA-MB-231 breast cancer cells is stabilized by elevated phospholipase D activity and contributes to survival signals generated by phospholipase D.
Academic Article
Mitomycin-DNA adducts induce p53-dependent and p53-independent cell death pathways.
Academic Article
Disruption of the p53-Mdm2 complex by Nutlin-3 reveals different cancer cell phenotypes.
Academic Article
p53 represses Sp1 DNA binding and HIV-LTR directed transcription.
Concept
Tumor Suppressor Protein p53
Academic Article
Targeting Triple Negative Breast Cancer with a Nucleus-Directed p53 Tetramerization Domain Peptide.
Academic Article
PARP-Targeted Auger Therapy in p53 Mutant Colon Cancer Xenograft Mouse Models.
Academic Article
The C-terminus of Gain-of-Function Mutant p53 R273H Is Required for Association with PARP1 and Poly-ADP-Ribose.
Academic Article
Patient-derived tumor organoids with p53 mutations, and not wild-type p53, are sensitive to synergistic combination PARP inhibitor treatment.
Academic Article
p53 suppresses MHC class II presentation by intestinal epithelium to protect against radiation-induced gastrointestinal syndrome.
Search Criteria
Tumor Suppressor Protein p53